drugset / Trial / NCT06839131

A Clinical Study of SPH9788 Tablets in Healthy Chinese Subjects.

NCT06839131 ↗

Phase 1 Recruiting 94 enrolled Shanghai Pharmaceuticals Holding Co., Ltd
RandomizedSequentialDouble-blindTreatment

Summary

The purpose of the study is to evaluate the safety of SPH9788 tablets in healthy subjects.

Timeline

Start
2025-03-02
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject SPH9788 Unknown — Oral

Indications

No indication recorded.